Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAGE
2726
Niagen Bioscience
NAGE
$239M
| $654K | ﹤0.01% |
427,200
-143,700
| -25% | -$256K |
|
2727
Harley-Davidson
HOG
$2.93B
| $653K | ﹤0.01% |
+17,200
| New | +$756K |
|
2728
Orion Group Holdings
ORN
$403M
| $653K | ﹤0.01% |
252,197
+19,900
| +9% | +$55.3K |
|
2729
Destination XL Group
DXLG
$36.3M
| $651K | ﹤0.01% |
118,200
+34,000
| +40% | +$216K |
|
2730
Ark Restaurants
ARKR
$20.2M
| $650K | ﹤0.01% |
36,811
+2,300
| +7% | +$42.3K |
|
|
SELF
2731
Global Self Storage
SELF
$59.5M
| $650K | ﹤0.01% |
126,390
-49,310
| -28% | -$259K |
|
2732
iShares MSCI Germany ETF
EWG
$1.68B
| $649K | ﹤0.01% |
22,800
+9,900
| +77% | +$273K |
|
2733
Lifecore Biomedical
LFCR
$175M
| $647K | ﹤0.01% |
171,451
+56,300
| +49% | +$314K |
|
|
MREO
2734
Mereo BioPharma
MREO
$51.3M
| $647K | ﹤0.01% |
915,909
-341,460
| -27% | -$307K |
|
2735
Edgewise Therapeutics
EWTX
$4.74B
| $646K | ﹤0.01% |
96,800
+19,200
| +25% | +$178K |
|
|
LOAN
2736
Manhattan Bridge Capital
LOAN
$47.2M
| $645K | ﹤0.01% |
124,528
+2,015
| +2% | +$11.2K |
|
2737
Assembly Biosciences
ASMB
$638M
| $644K | ﹤0.01% |
63,817
+21,868
| +52% | +$369K |
|
2738
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $644K | ﹤0.01% |
20,900
+13,600
| +186% | +$414K |
|
2739
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.05B
| $644K | ﹤0.01% |
12,400
+7,200
| +138% | +$372K |
|
|
SCWX
2740
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $644K | ﹤0.01% |
75,140
-1,700
| -2% | -$13.1K |
|
2741
Noodles & Co
NDLS
$109M
| $643K | ﹤0.01% |
16,560
-14,413
| -47% | -$658K |
|
|
ATXS
2742
DELISTED
Astria Therapeutics
ATXS
| $642K | ﹤0.01% |
48,300
-33,961
| -41% | -$459K |
|
2743
iShares MSCI Chile ETF
ECH
$1.04B
| $642K | ﹤0.01% |
22,300
+11,800
| +112% | +$334K |
|
|
LITS
2744
Lite Strategy Inc
LITS
$30.4M
| $642K | ﹤0.01% |
140,218
+7,000
| +5% | +$39.1K |
|
2745
Alaunos Therapeutics
TCRT
$4.79M
| $642K | ﹤0.01% |
6,799
-3,726
| -35% | -$355K |
|
2746
Lexicon Pharmaceuticals
LXRX
$1.04B
| $641K | ﹤0.01% |
263,875
-129,410
| -33% | -$297K |
|
2747
Neurogene
NGNE
$711M
| $640K | ﹤0.01% |
45,731
-13,941
| -23% | -$163K |
|
|
SASR
2748
DELISTED
Sandy Spring Bancorp Inc
SASR
| $640K | ﹤0.01% |
24,637
-19,900
| -45% | -$640K |
|
|
PHX
2749
DELISTED
PHX Minerals
PHX
| $638K | ﹤0.01% |
243,485
-73,415
| -23% | -$233K |
|
|
AAMC
2750
DELISTED
Altisource Asset Management Corp
AAMC
| $637K | ﹤0.01% |
+16,635
| New | +$424K |
|
Similar funds
Jim Simons's Q1 2023 Portfolio in Review
As of Q1 2023, Jim Simons held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Jim Simons added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Jim Simons's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Jim Simons fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Jim Simons's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Jim Simons opened 524 new positions and closed 668 in Q1 2023.
- Jim Simons's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.